Johnson & Johnson Comprehensive Income 2010-2024 | JNJ

Johnson & Johnson comprehensive income for the quarter ending September 30, 2024 was $-12.522B, a 42.62% increase year-over-year.

  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
  • Johnson & Johnson comprehensive income for 2022 was $-12.967B, a 0.7% decline from 2021.
  • Johnson & Johnson comprehensive income for 2021 was $-13.058B, a 14.33% decline from 2020.

Johnson & Johnson Comprehensive Income 2010-2024 | JNJ

  • Johnson & Johnson comprehensive income for 2023 was $-12.527B, a 3.39% decline from 2022.
  • Johnson & Johnson comprehensive income for 2022 was $-12.967B, a 0.7% decline from 2021.
  • Johnson & Johnson comprehensive income for 2021 was $-13.058B, a 14.33% decline from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$692.7B
Novo Nordisk (NVO)$460.6B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B